بررسی الگوی استفاده ، رضایتمندی و علل نگرانی ازمصرف داروهای استنشاقی در کودکان مبتلا به آسم از دیدگاه والدین

نویسندگان
علی حسینی نسب 1
شیما گروهی 2
نسرین بازرگان هرندی 2
علی خالوئی 2
1 مKerman Medical School - 22 Bahman Blvd- Kerman- Iran
2 وزارت بهداشت درمان وآموزش پزشکی
10.52547/jmj.16.3.1
چکیده
مقدمه : داروهای استنشاقی فراوانترین داروهای مورد استفاده در کنترل آسم در کودکان هستند.  این مطالعه با منظور بررسی میزان استفاده، رضایتمندی و علل نگرانی در خصوص مصرف داروای استشاقی  و عوامل موثر بر آن از دیدگاه والدین انجام شد.
 
مواد و روشها: این بررسی، یک مطالعه توصیفی –تحلیلی است که در کودکان مبتلا به آسم مراجعه کننده به  دو کلینک آسم و آلرژی  در بیمارستانهای آموزشی دانشگاه علوم پزشکی کرمان انجام شد.
 
نتایج: میانگین و انحراف معیار سن بیماران 4.01±7.58 سال بود. بیش از  95  درصد کودکان مبتلا در زمان مطالعه جهت کنترل آسم، دارو استفاده می کردند. در بیماران مصرف کننده داروی ضد آسم، 86.6 درصد آنها از داروهای استنشاقی به تنهایی یا همراه با داروهای خوراکی استفاده می نمودند. در بیمارانی که داروی استنشاقی استفاده می کردند، 73.7 درصد داروهای برنکودیلاتور همراه با کورتیکواستروئید ، 22 درصد برنکودیلاتور به تنهایی و 2.3 درصد کورتیکواستروئید به تنهایی استفاده می شد. بیش از 91 درصد از والدین از مصرف داروهای استشاقی برای کنترل آسم رضایت داشتند و 95.9 درصد آنها نگران عوارض این داروها بودند. وابستگی به دارو (90.1 درصد) و هزینه زیاد (81.3 درصد) به ترتیب شایعترین علل نگرانی والدین بودند.
 
نتیجه گیری: علیرغم رضایتمندی والدین از موثر بودن داروهای استنشاقی در درمان آسم کودکان، نگرانی از عوارض موجب محروم شدن کودکان  از استفاده از این داروهای اثربخش می شود. آموزش مناسب می تواند نگرش بیماران و والدین را اصلاح نموده و نگرانی در مورد مصرف این داروها را کاهش دهد.
کلیدواژه‌ها
آسم
داروهای استنشاقی
داروهای برنکودیلاتور
داروهای کورتیکواستروئید

عنوان مقاله English

Usage Pattern, Satisfaction, Causes of Concern and Related Factors of Metered Dose Inhalers in Children with Asthma, the Parents Perspective

نویسندگان English

Ali Hosseininasa 1
Shima Goroohi 2
Nasrin Bazargan Harandi 2
Ali Khalooei 2
چکیده English

Introduction
 Metered Dose Inhalers (MDIs) are the most common drugs for the control of asthma. This study was conducted to evaluate usage patterns, satisfaction with and concerns about MDIs for children with asthma and the related factors from the viewpoints’ of their parents.
Materials and methods
This cross-sectional study was conducted on children with asthma who referred to asthma and allergy clinics in two teaching hospitals of Kerman University of Medical Sciences in Iran.
Results
The mean and SD of age of the patients were 7.58±4.01 years. More than 95% of the patients were taking anti-asthmatic drugs at the time of the study. Of the patients who used anti-asthmatic drugs, 86.6% were using MDIs alone or in combination with oral anti-asthmatic drugs. Of patients who took MDIs, 73.7% were using a combination of bronchodilator and corticosteroid, 22% bronchodilator alone, and 2.3% corticosteroids alone. More than 91% of the parents were satisfied and 95.9 % of them were concerned about the usage of MDIs. Dependence to MDIs (90.1%) and high costs of MDIs (81.3%) were the most frequent causes of concern about MDIs usage.  
Conclusion
 Despite high satisfaction of parents with MDIs for control of asthma in children, concerns of parents about MDIs usage can cause the deprivation of children from these highly effective drugs. Proper education can correct attitudes of patients or parents and decrease their concerns about MDIs usage. 

کلیدواژه‌ها English

Asthma
metered dose inhalers
bronchodilator drugs
corticosteroid drugs
1.Carr TF, Beamer PI, Rothers J, Stern DA, Gerald LB, Rosales CB, Van Horne YO, Pivniouk ON, Vercelli D, Halonen M, Gameros M. Prevalence of Asthma in School Children on the Arizona-Sonora Border. J ALLERGY CLIN IMMUNOL PRACT. 2017 Feb 28;5(1):114-20. 2. Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2016 Jan 1;20(1):11-23. 3.Dal Negro RW, Distante C, Bonadiman L, Turco P, Iannazzo S. Cost of persistent asthma in Italy. Multidisciplinary respiratory medicine. 2016;11:44. 4.Mehravar F, Rafiee S, Bazrafshan B, Khodadost M. Prevalence of asthma symptoms in Golestan schoolchildren aged 6-7 and 13-14 years in Northeast Iran. Front. Med. 2016, 10(3): 345–350. 5.Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. . Int J Chron Obstruct Pulmon Dis. 2012; 7: 495–502.. 6. Bussey-Smith KL, Rossen RD. A systematic review of randomized control trials evaluating the effectiveness of interactive computerized asthma patient education programs. Ann Allergy Asthma Immunol. 2007 Jun;98(6):507-16. 7.Kshatriya RM, Khara NV, Paliwal RP, Patel SN. Evaluation of proficiency in using different inhaler devices among intern doctors J Family Med Prim Care. 2016 Apr-Jun;5(2):362-366. 8-Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006 Sep;100(9):1479-94. 9.Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices J Asthma. 2007 Oct;44(8):593-8. 10. Bozorgzad P, Ebadi A, Moin M, Sarhangy F, Nasiripour S, Soleimani MA. The effect of educating the use of spray by visual concept mapping method on the quality of life of children with asthma. Iranian Journal of Allergy, Asthma and Immunology. Iran J Allergy Asthma Immunol 2013 Mar; 12(1): 63-67. 2013 12(1):63. 11.Yasmin S, Mollah AH, Basak R, Islam KT, Chowdhury YS. Efficacy of salbutamol by nebulizer versus metered dose inhaler with home-made non-valved spacer in acute exacerbation of childhood asthma Mymensingh Med J. 2012 Jan;21(1):66-71. 12.Abu-Shaheen AK, Nofal A, Heena H. Parental Perceptions and Practices toward Childhood Asthma. BioMed research international. 2016;2016:6364194. 13. Sun HL, Kao YH, Chou MC, Lu TH, Lue KH. Differences in the prescription patterns of anti-asthmatic medications for children by pediatricians, family physicians and physicians of other specialties. J Formos Med Assoc. 2006 Apr;105(4):277-83 14. Santos DB, Cruz AA, de Magalhaes Simoes S, Rodrigues LC, Camargos PA, Coelho HL, et al. Pattern of asthma medication use among children from a large urban center in Brazil. Eur J Clin Pharmacol. 2012;68(1):73-82.15. 15. Uijen JH, van der Wouden JC, Schellevis FG, Willemsen SP, van Suijlekom-Smit LW, Bindels PJ. Asthma prescription patterns for children: can GPs do better?. Eur J Gen Pract. 2011 Jun 1;17(2):109-15. 16.Elkout H, Helms PJ, Simpson CR, McLay JS. Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysis. Arch Dis Child. 2012;97(6):521-5. 17. Arellano FM, Arana A, Wentworth CE, Vidaurre CF, Chipps BE. Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States. Pediatr Allergy Immunol. 2011 Aug 1;22(5):469-76. 18'Kamps AW, van Ewijk B, Roorda RJ, Brand PL. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol . 2000;29(1):39-42. 19. Nambu M, Holgate S. Differences in the asthma treatment of children between Europe and Japan: a questionnaire-based survey using model cases. World Allergy Organ J. 2009 Apr 15;2(4):54-56. 20.Gajanan G, Padbidri VS, Chaudhury A. Assessment of Knowledge and Attitude of Parents Towards the Allergy and Bronchial Asthma in Their Children. Int J Med. Public Health. 2016; 6(3): 121-125. 21.Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? J Pediatr Psychol 2006;31(8):846-58. 22.Hossny E, Rosario N, Lee BW, Singh M, El-Ghoneimy D, Soh JY, Le Souef P. The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organ J. 2016 Aug 12;9(1):1-26. 23.Burgess SW, Sly PD, Morawska A, Devadason SG. Assessing adherence and factors associated with adherence in young children with asthma. Respirology. 2008;13(4):559-63. 24. Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care. 2005 Oct 1;50(10):1346-59. 25. Murphy KR, Bender BG. Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence. J Asthma Allergy. 2009; 2: 63–72. 26.Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015 Sep 10;8(1):26-40.